In this conversation, Douglas Lucas discusses the newly discovered hormone CCN3 and its potential role in reversing osteoporosis. He explains the mechanism of CCN3, its effects on bone health, and the current state of research, emphasizing the need for human trials to confirm its efficacy. Lucas also highlights the importance of proactive measures for bone health and cautions against relying solely on new treatments.
